Starbucks (NASDAQ: SBUX) reported a 13% increase in second-quarter adjusted earnings to 60 cents per share, which exceeded analysts’ expectation of 56 cents per share. The announcement sent the shares up 1.5% during after-market trading on Thursday.
SBUX shares have gained 18.7% this year, outperforming the S&P 500 index, which has increased 16.8% during the same period.
On a GAAP basis, net income rose 12.8% to 53 cents per share, helped by a 5% growth in net sales to $6.31 billion. The top line came in line with the street expectation.
Global comparable sales rose 3%, in line with the street projection, driven by a 3% increase in average ticket.
READ: THE CANNABIS-BEVERAGE INDUSTRY IS SOMETHING YOU DON’T WANT TO MISS THIS YEAR
The second-quarter earnings come at a time when the coffee company is facing tight competition in its second-largest market – China. We had earlier reported how Chinese coffee joint Luckin Coffee is offering stiff resistance to Starbucks’ growth, by offering affordable coffee on the go.
Earlier this week, Luckin filed for a US IPO, to reportedly raise up to $800 million. All this has contributed to a recent spike in short interest in SBUX stock.
Outlook
Looking ahead into fiscal 2019, the company expects global comparable store sales growth between 3% and 4%. It is also aiming to open approximately 2,100 net new stores around the globe before the end of this year.
Starbucks raised its guidance for FY2019 Non-GAAP EPS in the range of $2.75 to $2.79. Previously it was projected to be in the range of $2.68 to $2.73.
Outlook for FY2019 GAAP EPS was raised to $2.40 to $2.44 from the prior range of $2.32 to $2.37.
Price target hike
Last week, Andrew Charles of Cowen raised the price target on the coffee chain from $63 to $69. However, the new price is still at a 9% discount from the current trading price.
Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!
Most Popular
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to
Hasbro (HAS) Q1 2024 Earnings: Key financials and quarterly highlights
Hasbro, Inc. (NASDAQ: HAS) reported first quarter 2024 earnings results today. Revenues decreased 24% year-over-year to $757.3 million. Net earnings attributable to Hasbro, Inc. were $58.2 million, or $0.42 per
BA Earnings: Highlights of Boeing’s Q1 2024 financial results
The Boeing Company (NYSE: BA) on Wednesday announced financial results for the first quarter of 2024, reporting a narrower net loss, on an adjusted basis. Revenues dropped 8%. Core loss,
